Foyston, Gordon, & Payne’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-18,798
Closed -$352K 68
2020
Q4
$352K Buy
+18,798
New +$307K 0.09% 64

Other funds holding VTRS

Foyston, Gordon, & Payne's VTRS Position: Q1 2021 in Review

Foyston, Gordon, & Payne sold out of Viatris (VTRS) in Q1 2021, closing a stake of 18,798 shares — an estimated $352K sold.

Foyston, Gordon, & Payne first reported a position in VTRS in Q4 2020 and held it in 1 quarter. The position peaked at $352K in Q4 2020. 1,115 funds tracked by Wall St. Rank hold VTRS as of Q1 2021.

  • Foyston, Gordon, & Payne reported no remaining Viatris position as of Q1 2021 after selling out during the quarter.
  • Foyston, Gordon, & Payne sold 18,798 Viatris shares in Q1 2021, an estimated $352K.
  • Foyston, Gordon, & Payne first reported a position in Viatris in Q4 2020 and held it in 1 quarter.
  • Foyston, Gordon, & Payne's Viatris position peaked at $352K in Q4 2020.
  • 1,115 funds tracked by Wall St. Rank held Viatris as of Q1 2021.

Based on Foyston, Gordon, & Payne's 13F filing for Q1 2021, filed 14 May 2021.